Compugen Ltd. (CGEN) vs Eledon Pharmaceuticals, Inc. (ELDN)

Compugen Ltd. and Eledon Pharmaceuticals, Inc. are both Biotechnology companies. Compugen Ltd. and Eledon Pharmaceuticals, Inc. are of similar size ($228.3M and $224.5M). Eledon Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Compugen Ltd. trades at 6.3×. Compugen Ltd. has the higher net margin (47.6% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Compugen Ltd. leads on 11 and Eledon Pharmaceuticals, Inc. on 1.

Valuation

Metric CGEN ELDN Biotechnology median
P/E 6.26 n/m 7.88
P/S 3.04 n/m 11.47
P/B 2.54 9.16 2.52
Price to free cash flow 5.63 n/m 21.16
EV/EBITDA 3.30 n/m 0.74
EV/Sales 1.35 n/m 10.73
Earnings yield 15.97% (34.21%) (28.84%)
Free cash flow yield 17.78% (24.43%) (23.03%)

Profitability

Metric CGEN ELDN Biotechnology median
Gross margin 86.89% 0.00% 65.16%
Operating margin 40.94% 0.00% 0.00%
Net margin 47.55% 0.00% 0.00%
Free cash flow margin 54.10% 0.00% 0.00%
Return on equity 47.85% (236.51%) (57.72%)
Return on assets 23.86% (72.74%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGEN ELDN Biotechnology median
Revenue growth (TTM) 234.18% — 5.64%
EPS growth (last fiscal year) 337.50% 30.67% —
Revenue growth, 5-year CAGR 105.20% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEN ELDN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.72 7.90 4.73
Net debt to EBITDA (4.65) 1.60 0.96

Dividend

Metric CGEN ELDN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CGEN ELDN Biotechnology median
Market cap 224.51m 228.34m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack